Search

everythinglearnresearchcommunity

for

Search:↓

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The testes control steroid production through complex interactions involving various cells and signaling molecules.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Prenatal antiandrogen treatment altered hormone levels in adult spotted hyenas, affecting males and females differently.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Most patients improved with oral contraceptives, but some needed additional treatment.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Male hormones and their interactions are crucial for male sexual development and characteristics.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.